Tag: Cancer: Prostate
Shorter Courses of Radiotherapy Increasingly Used for Prostate Cancer
Recent drop seen in proportion of patients receiving conventional fractionation; increase seen in moderate hypofractionation and ultrahypofractionation
Prostate-Specific Antigen Levels Posttreatment May Not Predict Overall Survival
Biochemical recurrence does not meet the criteria to be a reliable surrogate endpoint for overall survival
Common Cancer Screenings May Not Extend Life Longevity
Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy
Prostate MRI Has Independent Screening Value
In a recent study, 16 percent of men who responded to screening invite had positive screening MRI
FDA Approves Akeega for BRCA-Positive Metastatic Prostate Cancer
Akeega plus prednisone significantly improves radiographic progression-free survival in patients with castration-resistant prostate cancer
Care at High-Volume Radiation Treatment Centers Tied to Higher Survival
Findings seen among men with very high-risk prostate cancer
Survival Similar for Black, White Prostate Cancer Patients in Clinical Trial Setting
Median PFS, OS similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors
PSMA-PET Improves Prediction of Biochemical Recurrence in Prostate Cancer
Risk assessment for biochemical recurrence improved with addition of PSMA PET N1/M1 status to presurgical Cancer of the Prostate Risk Assessment score
Toxicity Reduced With MRI-Guided Radiotherapy for Prostate Cancer
Odds ratios for acute grade 2 or higher genitourinary and gastrointestinal toxicities reduced for MRg-A-SBRT versus CT-SBRT
For Prostate Cancer Info Videos, Patients Prefer Hearing From a Physician
And, racial concordance between patient and physician important for trust among Black adults
